Effects of miR-193a and sorafenib on hepatocellular carcinoma cells

BACKGROUND: Hepatocellular carcinoma (HCC) is a challenging malignancy of global importance, it is the third most common cause of cancer-related mortality worldwide. In the last years the multikinase inhibitor sorafenib has been used for advanced HCC, but some patients do not benefit from this thera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Salvi, Alessandro, Conde, Isabel, Abeni, Edoardo, Arici, Bruna, Grossi, Ilaria, Specchia, Claudia, Portolani, Nazario, Barlati, Sergio, De Petro, Giuseppina
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029516/
https://ncbi.nlm.nih.gov/pubmed/24330766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-12-162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados